Gene Therapy for AIDS
With the number of HIV infected individuals world-wide now estimated in the millions and with no curative treatment or protective vaccine available in the immediate future, all efforts should be pursued to develop novel treatment modalities for AIDS. One potential anti-HIV technology which is rapidly moving from the laboratory to the clinic is commonly refereed to as gene therapy. The nature of this technology, the potential methods by which it could be applied to combat HIV infection, as well as issues related to the safety and the practicality of administrating this technology on a large scale will be discussed.
KeywordsGene Therapy Producer Cell Line Packaging Cell Line Mouse Hematopoietic Stem Cell Primary Culture Endothelial Cell
Unable to display preview. Download preview PDF.
- 6.Malin, M. H., Bohnlein, S., Hauber, J., and Cullen, B.R. Functional dissection of the HIV-1 Rev trans-activator: derivation of a trans-dominant repressor of Rev function. Cell 1989; 58: 205–214.Google Scholar
- 10.Berger, E.A., Fuerst, T.R., and Moss, B. A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 2357–2361.PubMedCrossRefGoogle Scholar
- Culver, K.W., Morgan, R.A., Osborne, W.R.A., Lee, R.T., Lenschow, D., Able, C., Cornetta, K., Anderson, W.F., and Blaese, R.M. In vivo expression and survival of gene-modified T lymphocytes in rhesus monkeys. Human gene therapy, in apress.Google Scholar